OMALIZUMAB FOR TWO PATIENTS WITH SEVERE PERSISTENT BRONCHIAL ASTHMA (A UKMMC EXPERIENCE)

被引：0
|
作者：
Fuad, Z. Mohamed [1 ]
Soo, C. I. [1 ]
Hamid, F. Abdul [1 ]
Ban, A. Y. L. [1 ]
Hassan, T. M. [1 ]
Manap, R. Abdul [1 ]
机构：
[1] Univ Kebangsaan Malaysia, Med Ctr, Resp Unit, Dept Internal Med, Kuala Lumpur, Malaysia
来源：
RESPIROLOGY | 2016年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
APSR6-0183
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [21] Side effects and clinical course of omalizumab in patients with severe persistent asthma
    Didem, Arzu Y.
    Erbay, R.
    Polat, H.
    Gumuslu, S.
    ALLERGY, 2012, 67 : 452 - 453
  • [22] Bronchial Thermoplasty for Severe Persistent Asthma
    Riddell, P.
    Lawrie, I.
    Zaidi, S.
    Lane, S.
    Egan, J. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S459 - S459
  • [23] Bronchial Thermoplasty in Patients with Severe Persistent Asthma: A Literature Review
    Aftab, Ghulam Mustafa
    Rehman, Sana
    Ahmad, Mudassar
    Akram, Ali
    Bukhari, Amar
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2021, 11 (04): : 518 - 522
  • [24] Effectiveness of 52 weeks of omalizumab therapy in patients with severe persistent allergic asthma
    Skiepko, R.
    Zietkowski, Z.
    Tomasiak, M.
    Lenczewska, D.
    Bodzenta-Lukaszyk, A.
    Skiepko, R.
    Skiepko, R.
    ALLERGY, 2010, 65 : 552 - 553
  • [25] Optimisation of Omalizumab Dosage in Patients with Severe Persistent Allergic Asthma Using recoveryELISA
    Jens-Oliver Steiß
    G. Becher
    BioDrugs, 2014, 28 : 445 - 450
  • [26] The impact of the addition of omalizumab on the utilization of healthcare resources by severe persistent asthma patients
    Dyer, Sarah
    Packham, Stuart
    Davies, Sarah
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [27] Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma
    Korn, Stephanie
    Schumann, Christian
    Kropf, Cornelia
    Stoiber, Kathrin
    Thielen, Antje
    Taube, Christian
    Buhl, Roland
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 105 (04) : 313 - 319
  • [28] Optimisation of Omalizumab Dosage in Patients with Severe Persistent Allergic Asthma Using recoveryELISA
    Steiss, Jens-Oliver
    Becher, G.
    BIODRUGS, 2014, 28 (05) : 445 - 450
  • [29] Reasons for discontinuation of Omalizumab therapy in the treatment of patients with moderate to severe persistent asthma
    Sheinkopf, L. E.
    Rafi, A. W.
    Do, L. T.
    Klaustermeyer, W. B.
    Katz, R. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S139 - S139
  • [30] Omalizumab in patients with severe persistent asthma in real life setting in Manisa, Turkey
    Havlucu, Y.
    Yorgancioglu, A.
    Kurhan, F.
    Ozdemir, L.
    Coskun, Sakar A.
    Goktalay, T.
    Yilmaz, O.
    Celik, P.
    ALLERGY, 2014, 69 : 292 - 292
12345